Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: Observational cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 12 08 2020
accepted: 23 09 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Hospital emergency departments play a crucial role in the initial assessment and management of suspected COVID-19 infection. This needs to be guided by studies of people presenting with suspected COVID-19, including those admitted and discharged, and those who do not ultimately have COVID-19 confirmed. We aimed to characterise patients attending emergency departments with suspected COVID-19, including subgroups based on sex, ethnicity and COVID-19 test results. We undertook a mixed prospective and retrospective observational cohort study in 70 emergency departments across the United Kingdom (UK). We collected presenting data from 22445 people attending with suspected COVID-19 between 26 March 2020 and 28 May 2020. Outcomes were admission to hospital, COVID-19 result, organ support (respiratory, cardiovascular or renal), and death, by record review at 30 days. Mean age was 58.4 years, 11200 (50.4%) were female and 11034 (49.6%) male. Adults (age >16 years) were acutely unwell (median NEWS2 score of 4), frequently had limited performance status (46.9%) and had high rates of admission (67.1%), COVID-19 positivity (31.2%), organ support (9.8%) and death (15.5%). Children had much lower rates of admission (27.4%), COVID-19 positivity (1.2%), organ support (1.4%) and death (0.3%). Similar numbers of men and women presented to the ED, but men were more likely to be admitted (72.9% v 61.4%), require organ support (12.2% v 7.7%) and die (18.2% v 13.0%). Black or Asian adults tended to be younger than White adults (median age 54, 50 and 67 years), were less likely to have impaired performance status (43.1%, 26.8% and 51.6%), be admitted to hospital (60.8%, 57.3%, 69.6%) or die (11.6%, 11.2%, 16.4%), but were more likely to require organ support (15.9%, 14.3%, 8.9%) or have a positive COVID-19 test (40.8%, 42.1%, 30.0%). Adults admitted with suspected and confirmed COVID-19 had similar age, performance status and comorbidities (except chronic lung disease) to those who did not have COVID-19 confirmed, but were much more likely to need organ support (22.2% v 8.9%) or die (32.1% v 15.5%). Important differences exist between patient groups presenting to the emergency department with suspected COVID-19. Adults and children differ markedly and require different approaches to emergency triage. Admission and adverse outcome rates among adults suggest that policies to avoid unnecessary ED attendance achieved their aim. Subsequent COVID-19 confirmation confers a worse prognosis and greater need for organ support. ISRCTN registry, ISRCTN56149622, http://www.isrctn.com/ISRCTN28342533.

Sections du résumé

BACKGROUND
Hospital emergency departments play a crucial role in the initial assessment and management of suspected COVID-19 infection. This needs to be guided by studies of people presenting with suspected COVID-19, including those admitted and discharged, and those who do not ultimately have COVID-19 confirmed. We aimed to characterise patients attending emergency departments with suspected COVID-19, including subgroups based on sex, ethnicity and COVID-19 test results.
METHODS AND FINDINGS
We undertook a mixed prospective and retrospective observational cohort study in 70 emergency departments across the United Kingdom (UK). We collected presenting data from 22445 people attending with suspected COVID-19 between 26 March 2020 and 28 May 2020. Outcomes were admission to hospital, COVID-19 result, organ support (respiratory, cardiovascular or renal), and death, by record review at 30 days. Mean age was 58.4 years, 11200 (50.4%) were female and 11034 (49.6%) male. Adults (age >16 years) were acutely unwell (median NEWS2 score of 4), frequently had limited performance status (46.9%) and had high rates of admission (67.1%), COVID-19 positivity (31.2%), organ support (9.8%) and death (15.5%). Children had much lower rates of admission (27.4%), COVID-19 positivity (1.2%), organ support (1.4%) and death (0.3%). Similar numbers of men and women presented to the ED, but men were more likely to be admitted (72.9% v 61.4%), require organ support (12.2% v 7.7%) and die (18.2% v 13.0%). Black or Asian adults tended to be younger than White adults (median age 54, 50 and 67 years), were less likely to have impaired performance status (43.1%, 26.8% and 51.6%), be admitted to hospital (60.8%, 57.3%, 69.6%) or die (11.6%, 11.2%, 16.4%), but were more likely to require organ support (15.9%, 14.3%, 8.9%) or have a positive COVID-19 test (40.8%, 42.1%, 30.0%). Adults admitted with suspected and confirmed COVID-19 had similar age, performance status and comorbidities (except chronic lung disease) to those who did not have COVID-19 confirmed, but were much more likely to need organ support (22.2% v 8.9%) or die (32.1% v 15.5%).
CONCLUSIONS
Important differences exist between patient groups presenting to the emergency department with suspected COVID-19. Adults and children differ markedly and require different approaches to emergency triage. Admission and adverse outcome rates among adults suggest that policies to avoid unnecessary ED attendance achieved their aim. Subsequent COVID-19 confirmation confers a worse prognosis and greater need for organ support.
REGISTRATION
ISRCTN registry, ISRCTN56149622, http://www.isrctn.com/ISRCTN28342533.

Identifiants

pubmed: 33237907
doi: 10.1371/journal.pone.0240206
pii: PONE-D-20-25198
pmc: PMC7688143
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0240206

Subventions

Organisme : Department of Health
ID : 11/46/07
Pays : United Kingdom

Déclaration de conflit d'intérêts

All authors declare grant funding to their employing institutions from the National Institute for Health Research (NIHR), as outlined under financial disclosure information. SG is Deputy Director of the NIHR Health Technology Assessment (HTA) Programme, which funded the study, and chairs the NIHR HTA commissioning committee. These competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Biomed Res Int. 2017;2017:9060852
pubmed: 28812025
EClinicalMedicine. 2020 Oct;27:100518
pubmed: 32864588
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Lancet Infect Dis. 2020 Jul;20(7):767-769
pubmed: 32422199
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Emerg Med J. 2016 Sep;33(9):665-70
pubmed: 27044949
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Health Technol Assess. 2015 Jan;19(3):v-xxi, 1-69
pubmed: 25587699
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Steve Goodacre (S)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Ben Thomas (B)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Ellen Lee (E)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Laura Sutton (L)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Amanda Loban (A)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Simon Waterhouse (S)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Richard Simmonds (R)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Katie Biggs (K)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Carl Marincowitz (C)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Jose Schutter (J)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Sarah Connelly (S)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Elena Sheldon (E)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Jamie Hall (J)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Emma Young (E)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Andrew Bentley (A)

Intensive Care, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.

Kirsty Challen (K)

Emergency Department, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.

Chris Fitzsimmons (C)

Emergency Department, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.

Tim Harris (T)

Emergency Department, Barts Health NHS Trust, London, United Kingdom.

Fiona Lecky (F)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Andrew Lee (A)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Ian Maconochie (I)

Emergency Department, Imperial College Healthcare NHS Trust, London, United Kingdom.

Darren Walter (D)

Emergency Department, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH